Request for Applications - CMCR Grants Program
The Center for Medicinal Cannabis Research (CMCR) is seeking to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts. Click here for further information and deadlines.
Current CMCR studies
Current studies examine the effects of cannabis on pain and the potential benefits of CBD tinctures in the treatment of autistic children as well as public safety issues surrounding the use of cannabis and cannabinoids. The CMCR has recently funded 5 new research studies and as recruitment begins, the details of those studies can be found here.
2019 CMCR Symposium
On Friday, October 18, 2019 the Center for Medicinal Cannabis Research (CMCR) held a one-day symposium celebrating the pioneers and exploring the progress, promise, and challenges of medicinal cannabis research. Click here to view an archive of the event broadcast.
- All
- Announcements
- Current Studies
- Information
- News
- Presentations
- Publications
- Studies
- Symposia
- Default
- Title
- Date
- Random
-
Marilynn Larkin, Reuters Health, April 30, 2020 In a recently published paper, Ron Ellis and colleagues found that cannabis may…Read More -
Shalina Chatlani, KPBS, December 19, 2019 More people are buying marijuana since California legalized its retail sale two years ago.…Read More -
The Center for Medicinal Cannabis Research (CMCR) is seeking to fund primary and pilot cannabis-related studies that further enhance the…Read More -
Alicia Wallace, CNN Business, January 2, 2020 As a growing number of states legalize cannabis, health officials are increasingly sounding…Read More -
Emily Land, San Francisco AIDS Foundation, February 24, 2020 In a recently published paper, Caitlin Wei-Ming Watson and CMCR colleagues…Read More -
Study results show that cannabis may have a beneficial impact on HIV-associated blood brain barrier injury.Read More -
Shalina Chatlani, KPBS, December 20, 2019 Marijuana is hard to police. A small amount may significantly impair a novice user…Read More -
Ashleigh Papp, San Jose Mercury News, January 2, 2020 Scientists must obtain hard-to-get license from DEA in order to conduct…Read More -
The Center for Medicinal Cannabis Research (CMCR) at UC San Diego has been a leader in medical marijuana research since…Read More
-
January 3, 2019 David McNew explored the complexities in assessing cannabis associated impairment in his article for NBC News. Read…Read More -
Amy Norton, HealthDay, August 9, 2019 As the CBD craze sweeps the nation, some users may wonder whether the cannabis…Read More -
-
Nick Musica, CBD Oil Review, August 21, 2019 Recently, Nick Musica of CBD Oil Review had the privilege of speaking…Read More -
Findings suggest cannabis exposure is linked to a lower odds of neurocognitive impairment in the context of HIV. A possible…Read More
-
Scott LaFee, UC San Diego News Center, October 10, 2019 The Center for Medicinal Cannabis Research (CMCR) at University of…Read More -
Information and materials for this event are available from the FDA at: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds May 31, 2019 Erika Edwards previewed the…Read More -
Angelica LaVito, CNBC, May 31, 2019 Food and Drug Administration regulators grilled manufacturers and advocates Friday for evidence that CBD…Read More -
Jared Aarons, ABC 10News San Diego, September 10, 2019 Starting this fall, the Pacific College of Oriental Medicine is offering…Read More -
June 20, 2019 Abbie Bennett, in an article written for Radio.com illustrated the political struggles surrounding the study of medical…Read More
load more
hold SHIFT key to load all
load all